a Final concentration after mixing.
b Tested in sodium chloride 0.9%.
c Tested in both dextrose 5% and sodium chloride 0.9%.
d Test performed using the Cubicin formulation.
f Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
g Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
h Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.
i Tested in dextrose 5%, sodium chloride 0.9%, and Ringers injection, lactated.
j Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.